Delivery Order SPE2DB22D1202-SPE2DB26FUEY8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zymfentra 120 mg/mL pens in a two-pack quantity, with a ceiling value of $1,503.56 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of October 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml Pen (2-pack) on September 17, 2025, with an ultimate completion date of October 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Zymfentra 120 mg/ml pen (2-packs) with a ceiling value of $3,007.12. This firm fixed price delivery order is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to...
- The Defense Logistics Agency awarded a $1,503.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) units, with an ultimate completion date of October 10, 2025. This non-set-aside competitive award was issued on September 19, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,503.56 delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) with a completion date of September 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The award was issued on September 9, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $6,014.24 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zymfentra 120 mg/ml pens (2-pack). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 25, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- On September 22, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $6,014.24 to AmerisourceBergen Drug Corp for the supply of Zymfentra 120 mg/ml pens in a two-pack configuration. This firm fixed-price delivery order, with an ultimate completion date of October 14, 2025, represents a non-competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026....
- The Defense Logistics Agency awarded a $1,503.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zymfentra 120 mg/ml pen (2-pack) pharmaceutical supplies on September 29, 2025, with completion targeted for October 21, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zymfentra 120 mg/ml Pen (2-pack) with a ceiling value of $1,503.56. This competitive, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a pediatric diabetes medication delivery supporting federal medical procurement requirements. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,503.56 to AmerisourceBergen Drug Corp for Zymfentra 120 mg/mL pen (2-pack) pharmaceutical supplies. This firm fixed-price delivery order, issued on July 31, 2025, with an ultimate completion date of August 21, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract issued under a larger indefinite...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB26FUEY8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Zymfentra 120 mg/ml pen (2-pack) with a ceiling value of $1,503.56. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by November 5, 2025, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC SPE2DX) with DLA Troop Support Medical, a $999,999,999 comprehensive pharmaceutical support vehicle valued through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems. The company's contract portfolio with DLA demonstrates extensive capability in supplying pharmaceutical products across multiple therapeutic domains, including specialty medications, vaccines, and medical devices to support Defense Health Agency and other federal healthcare customers. This particular delivery order represents a discrete transaction for diabetes management medication within the broader framework of the company's global pharmaceutical supply agreement with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/15/25 |